Alzamend Neuro lithium imaging data accepted for oral presentation
Alzamend Neuro says its Phase 1/2A lithium imaging data has been accepted for an oral presentation at the ISMRM Workshop on X-Nuclei MR in Barcelona, Spain.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.